Natural Accelerator (previously Isagenix Natural Accelerator) (Isagenix Asia Pacific Australia Pty Ltd)
Product Name
Natural Accelerator (previously Isagenix Natural Accelerator)
ARTG details
Date of review outcome
Date of publication
Sep-2026
Outcome
Medicine continues to be permitted for supply
Is it safe to continue using this medicine?
Yes, based on the sponsor's certification. However, follow the recommended actions below.
What action should consumers take?
This medicine should be taken by adults only.
Consider whether this medicine is right for you based on it potentially not working as expected in relation to weight loss and management, antioxidant and anti-inflammatory properties, burning fat and calories, fat and protein metabolism, improving digestion and supporting general wellbeing.
Consider whether this medicine is right for you based on it potentially not working as expected in relation to weight loss and management, antioxidant and anti-inflammatory properties, burning fat and calories, fat and protein metabolism, improving digestion and supporting general wellbeing.
Review scope
Targeted
Information reviewed
ARTG Record, Labels, Website
Issues related to safety
The website for this medicine was missing the mandatory warning statement specified in 'What action should consumers take?' above. This warning statement is necessary to ensure the safe use of this medicine.
While the absence of a warning statement is unacceptable, the warning statement is included on the label, and the website has been updated. As such, this medicine is unlikely to pose an immediate risk to consumer health and safety.
While the absence of a warning statement is unacceptable, the warning statement is included on the label, and the website has been updated. As such, this medicine is unlikely to pose an immediate risk to consumer health and safety.
Issues related to efficacy
The website contained claims specified in 'What action should consumers take?' above. However, these claims were not covered by the sponsor’s certification that they held evidence to substantiate them.
Actions taken during the review
The TGA required the sponsor to correct the issues with this medicine. The sponsor updated the website to correct these issues.